Text Size
182 studies found for:    Open Studies | "Heparin"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Heparin"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Comparison of Dilute Versus Concentrated Heparin for CRRT Anticoagulation
Conditions: Acute Kidney Injury;   Acute Renal Failure;   Heart Failure
Interventions: Drug: Dilute unfractionated heparin;   Drug: Standard concentration unfractionated heparin
2 Recruiting DEDICA (Dose of HEparin During Coronary Angioplasty) Trial
Conditions: Stable Angina;   Angina, Unstable;   Non-ST Elevation (NSTEMI) Myocardial Infarction
Interventions: Drug: Low-dose heparin;   Drug: Standard dose heparin
3 Recruiting Safety of Heparin in Patients With Septic Shock
Condition: Sepsis
Intervention: Drug: heparin
4 Unknown † OPG and RANKL Plasma Level After Administration of Unfractionated Heparin (UFH) and Low-Molecular-Weight Heparin (LMWH) in Hemodialysis
Conditions: Renal Failure;   Hemodialysis
Interventions: Drug: law molecular weigth heparin;   Drug: unfractioned heparin
5 Recruiting Balloon Aortic Valvuloplasty Performed Without Heparin to Decrease Vascular and Bleeding Complications of the Procedure
Condition: Aortic Stenosis, Non-rheumatic
Interventions: Drug: Heparin;   Drug: NaCl
6 Recruiting Using Intravenous Heparin Versus Standard of Care Subcutaneous Heparin to Prevent Clots After Surgery
Condition: Venous Thrombosis
Interventions: Drug: low dose intravenous heparin (LDIVH);   Drug: Heparin
7 Recruiting Efficacy & Safety of ODSH (2-0, 3-0 Desulfated Heparin) in Patients With Metastatic Pancreatic Cancer Treated With Gemcitabine & Abraxane
Condition: Metastatic Pancreatic Cancer
Interventions: Drug: Abraxane ( Nab-paclitaxel);   Drug: Gemcitabine;   Drug: ODSH ( 2-O, 3-O Desulfated Heparin);   Drug: Abraxane ( nab-paclitaxel)
8 Recruiting Understanding "Heparin Resistance" in Cardiac Surgery
Conditions: Cardiopulmonary Bypass;   Altered Heparin Response
Interventions: Drug: Heparin;   Drug: ATryn
9 Unknown † Efficacy And Safety Of Unfractionated Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary Bypass
Condition: Prevention of Venous Thromboembolism
Interventions: Biological: bovine heparin;   Biological: Porcine heparin
10 Unknown † Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure
Condition: Chronic Renal Failure
Intervention: Biological: heparin sodium
11 Unknown † Efficacy and Safety of Sodium Heparin in Patients Submitted to Heart Surgery Using Bypass
Condition: Cardiac Surgery
Interventions: Drug: heparin sodium - Bergamo;   Drug: heparin sodium - APP
12 Recruiting Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients
Conditions: Obesity;   Morbid Obesity;   Venous Thromboembolism;   Atrial Fibrillation;   Angina;   Chest Pain
Intervention: Drug: Lean Body Weight-based heparin dose
13 Recruiting Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction
Condition: Myocardial Infarction
Interventions: Drug: Prasugrel;   Drug: Bivalirudin;   Drug: Clopidogrel;   Drug: Heparin
14 Not yet recruiting Trial of Nebulized Heparin Versus Placebo for Inhalation Trauma
Conditions: Inhalation Injury;   Burn Injury
Interventions: Drug: unfractionated heparin;   Drug: placebo
15 Unknown † Efficacy And Safety Of Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary Bypass
Condition: Prevention of Venous Thromboembolism
Interventions: Biological: Bovine Heparin;   Biological: Porcine heparin
16 Not yet recruiting PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (SUBCUTANEOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS
Condition: Healthy
Intervention: Drug: Heparin
17 Not yet recruiting PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (INTRAVENOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS
Condition: Healthy
Intervention: Drug: Heparin
18 Recruiting ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.
Conditions: The Primary Study Objective is to Assess the Efficacy and;   Safety of Extended 4-week Heparin Prophylaxis Compared to;   Prophylaxis Given for 8±2 Days After Planned Laparoscopic;   Surgery for Colorectal Cancer.;   The Clinical Benefit Will be Evaluated as the Difference in;   the Incidence of VTE or VTE-related Death Occurring Within 30 Days;   From Surgery in the Two Study Groups.
Intervention: Drug: Heparin, Low-Molecular-Weight
19 Recruiting Propaten Randomized Investigation on Cost-benefit and Efficacy
Condition: End-stage Renal Disease
Interventions: Device: Heparin-bonded vascular access graft;   Device: Conventional ePTFE hemodialysis graft
20 Unknown † Comparison of Slow Efficiency Daily Dialysis (SLEDD) With Unfractionated Heparin Versus Citrasate in Critically Ill Patients.
Conditions: Acute Kidney Injury;   Hemodialysis
Interventions: Drug: Unfractionated heparin;   Drug: Citrasate
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years